Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.319 EUR | +5.11% | +2.90% | -18.21% |
Apr. 04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.21% | 13.51M | |
+24.45% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.21% | 25.78B | |
-20.95% | 19.26B | |
+2.95% | 12.14B | |
-2.23% | 12.08B | |
+30.55% | 11.98B |
- Stock Market
- Equities
- CYAD Stock
- News Celyad Oncology SA
- Transcript : Celyad Oncology SA, 2022 Earnings Call, Mar 24, 2023